MINI REVIEW: BLACK RICE (Oryza sativa L. Indica) AS POTENTIAL FOOD FOR ANTIHYPERGLYCAEMIC
Main Article Content
Abstract
In Indonesia, rice (Oryza sativa L.) has different colors and shapes, visible from the plants and rice. There are several types of rice, one of which is black rice (Oryza sativa L. indica). Researchers are motivated to explore the benefits of black rice in Indonesia. This interest stems from the potential health benefits of black rice, such as its benefits in treating diabetes mellitus. The effectiveness of reducing blood sugar levels is crucial in the context of the increasing prevalence of diabetes in Indonesia, as projected by the International Diabetes Federation for 2045. The author made observations on the phytochemical and pharmacological activities of black rice, aiming to lay the foundation for further study and development. By searching online journals in the Scopus and PubMed databases using the keywords (“Black Rice”) AND (antidiabetic) OR (diabetes) OR (“glucose lowering”) for the last 10 years, the filtering process produced 3 articles on Scopus and 5 articles on PubMed, providing accurate data for review. Results show that black rice contains bioactive compounds such as flavonoids, phytic acid, polyphenolic compounds, and oryzanol, which provide significant health benefits. Anthocyanins, the main compounds responsible for the color of rice, contribute to antihyperglycemic properties and have various pharmacological activities, one of which is anti-diabetic benefits. In addition, the high content of anthocyanins, fiber, and other nutrients in black rice makes it effective in managing the glycemic index, and blood glucose levels, and improving overall health ...
Article Details
Copyright Notice
 The author whose manuscript was published agreed to the following provisions:
- The publication right of all journal material published / released on the E-Journal website of the Medical Science Journal: The Pharmaceutical Scientific Journal is held by the editorial board with the author's knowledge (the moral rights remain the manuscript's author).
- Formal legal provisions for access to digital articles in electronic journals are subject to Creative Commons Attribution-ShareAlike (CC BY-SA) license terms, which means Medical Science Journal: Pharmaceutical Scientific Journal has the right to store, transfer media / format, manage in the form of database (database), maintain, and publish articles without asking permission from the author as long as they include the author's name as the copyright owner.
- Manuscripts that are published / released in print and electronically are open access for educational, research and library purposes. In addition to these objectives, the editorial board is not responsible for violations of copyright law.
Â
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.